ARTICLE | Company News
Thallion cancer news
June 15, 2009 7:00 AM UTC
Thallion restructured and reduced headcount to 30-35 from 42-43 and has negotiated with its suppliers and other commitments to save cash. Thallion's lead compound is TLN-4601. The farnesylated dibenz...